Definitive Contract 75D30121C11656
Award Date
7/1/21
Potential Completion Date
8/31/23
Potential Value
$14M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AJ12 - General Science And Technology R&D Services; General Science And Technology; Applied Research
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $13,460,835.60 delivery order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Vanderbilt University Medical Center. The contract is for an Adult Inpatient and Outpatient VE Case Control Study, which will evaluate the effectiveness of COVID-19 and influenza vaccines. This order falls under the larger Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) indefinite delivery/indefinite quantity...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $4.8 million definitive contract to Vanderbilt University Medical Center to conduct research titled "Innovative Methods to Evaluate the Role of Influenza Vaccines in Attenuating Severe Disease in Adults." The prime contractor will lead a network of 16 academic medical centers as subcontractors to study the effectiveness of influenza vaccines in preventing critical illness. This award was...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $49,995,944 definitive cost-no-fee contract to Vanderbilt University Medical Center for Surveillance of Acutely Ill Adults with Respiratory Viruses, Including SARS-CoV-2. Vanderbilt University Medical Center will serve as the prime contractor and has subcontracted portions of the work to 26 other institutions, including The Cleveland Clinic Foundation, University of Utah, Beth Israel Deaconess...
This is a $12,797,150.73 Definitive Contract awarded by the Centers for Disease Control and Prevention (CDC) to Vanderbilt University Medical Center (VUMC), a major academic medical center and nonprofit healthcare provider, for a new network of household transmission studies to evaluate vaccine effectiveness. The contract has a performance period ending on March 28, 2025 and utilizes a Firm Fixed Price pricing arrangement. VUMC is serving as the prime contractor and has awarded subcontracts to...
This firm fixed price contract from the Centers for Disease Control and Prevention (CDC) to Vanderbilt University Medical Center (VUMC) evaluates the effectiveness of vaccines against COVID-19, influenza, and respiratory syncytial virus (RSV) among U.S. adults with severe acute respiratory illness. The $11,908,903.84 potential value contract monitors effectiveness against COVID-19, influenza, and emerging variants, as well as duration of protection. It also conducts RSV surveillance and builds...
This is a prime contract award from the Centers for Disease Control and Prevention (CDC) to Vanderbilt University Medical Center (VUMC), a leading academic medical center and nonprofit healthcare provider. The $33,581,705.97 fixed-price contract, awarded under the CDC's Fiscal Year 2021 Broad Agency Announcement, supports VUMC's research on topics related to Topic 9.1. The contract has no set-aside designation. VUMC is a major recipient of federal funding and has extensive experience managing...
This is a firm fixed-price federal contract award to Vanderbilt University Medical Center (VUMC), a non-profit healthcare provider in Nashville, Tennessee. The contract was awarded by the Centers for Disease Control and Prevention (CDC) on December 18, 2020 for $3,749,778.73 to support COVID-19 host pathogen discovery research under the CDC's Broad Agency Announcement (BAA) program. The contract has a period of performance through November 29, 2022. VUMC, which has a long history of federal...
The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a $1,906,532.45 firm fixed price contract to Vanderbilt University Medical Center (VUMC) to conduct the Influenza Vaccine Effectiveness in the CriticallY Ill (IVY) study. The IVY study is a multicenter prospective observational study focused on influenza infection among hospitalized adults, with a focus on critically ill patients in intensive care units. VUMC will serve as the Clinical...
This is a federal contract award to The Vanderbilt University, a private research university, by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) for CLINICAL EVALUATION LEAD SITE services. The $4,879,802.00 contract is a Delivery Order under the larger Clinical Immunization Safety Assessment (CISA) contract vehicle. The award does not have a set-aside designation. As the prime contractor, Vanderbilt University will provide critical research and...
This is a cost-no-fee definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Johns Hopkins University, a private research university, to provide COVID-19 response efforts. The $1,835,654.79 contract has a performance period running from July 1, 2020 through June 30, 2023. As part of this contract, Vanderbilt University Medical Center (VUMC) is serving as a subcontractor to provide molecular testing and epidemiology support, including day-to-day supervision...